Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

tuberculous fibrosis of lung News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A corrigendum has been issued for the study on fluvoxamine's effects on bleomycin-induced lung fibrosis, highlighting its role in regulating the cGAS-STING pathway. This research contributes to understanding potential therapeutic approaches for lung fibrosis.

A recent study highlights post varicella lung fibrosis as a significant complication following viral pneumonia. This research underscores the long-term pulmonary impacts of varicella infection, warranting further investigation into treatment options.

Not rare diseases news,news about your rare disease.

Earlier

A corrigendum has been issued for the study on fluvoxamine's effects on bleomycin-induced lung fibrosis, highlighting its role in regulating the cGAS-STING pathway. This research contributes to understanding potential therapeutic approaches for lung fibrosis.

A recent study highlights post varicella lung fibrosis as a significant complication following viral pneumonia. This research underscores the long-term pulmonary impacts of varicella infection, warranting further investigation into treatment options.

Not rare diseases news,
news about your rare disease.